HTG Names Renowned RNA Expert Dr. Robert Spitale to Therapeutics Scientific Advisory Board
February 3, 2022
TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed Robert Spitale, Ph.D., Associate Director and Associate Dean of Research in the School of Pharmacy and Pharmaceutical Services at the University of California, Irvine (UC Irvine), to the [...]
Impilo and SHS acquire Lowenco
February 3, 2022
VAMDRUP, Denmark – Impilo and SHS have acquired Lowenco A/S (“Lowenco” or the “Company”) from its founder and owners. Lowenco was founded 2013 in Vamdrup, Denmark, and develops, manufactures, markets, and installs large scale modular and highly energy efficient ultra-low temperature (“ULT”) storage solutions for commercial biopharma, primarily targeting the drug substance market. Following an initial [...]
BGL Announces the Sale of Lowenco to Impilo and SHS
February 3, 2022
Brown Gibbons Lang & Company (BGL), a leading investment banking and financial advisory firm, is pleased to announce the sale of Lowenco A/S (Lowenco), a leading manufacturer of ultra-low temperature (ULT) storage solutions for the pharma industry, to Impilo and SHS. BGL’s Healthcare & Life Sciences investment banking team initiated the transaction and acted as the exclusive [...]
February 3, 2022
Joint study will assess clinical value of comprehensive genomic profiling (CGP) on cancer therapy options in patients with advanced disease SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN), today announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University Hospital in France to assess the clinical value of comprehensive genomic profiling (CGP) in cancer therapy [...]
Biosero Joins Genedata Ready-to-Run Program to Streamline Lab Automation and Data Analysis
February 3, 2022
Biosero, Inc., now a member of the BICO Group and, developer of laboratory automation solutions to orchestrate scientific discoveries, today announced that it has joined the Genedata Ready-to-Run program, which helps to accelerate drug discovery with frictionless integrations that streamline laboratory automation processes in biopharmaceutical companies. Through this agreement, customers of both companies will experience [...]
The First Dedicated Electron Diffractometer – With QUADRO Inside – Soon in Operation!
February 3, 2022
Founded in 2019, ELDICO Scientific embarked on an ambitious journey: The company wants to make electron diffraction, a promising analytical technique for nano-scale research, easy and accessible to the industry and academia. This February, ELDICO is about to put its first dedicated electron diffractometer into operation at Europe’s first electron diffraction platform hosted by the Switzerland Innovation Park [...]
Axion BioSystems Expands Operations with Acquisition of M-Solv Manufacturing Limited
February 3, 2022
ATLANTA -- Axion BioSystems, a leading life sciences tools company focused on advanced bioelectronic assay technologies, announces the acquisition of UK-based printed electronics manufacturer M-Solv Manufacturing Limited, a subsidiary of M-Solv Ltd. The creation of the new division, called Axion BioSystems Manufacturing, UK, Ltd., cements the six-year partnership between the companies and positions Axion for continued growth [...]
February 3, 2022
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples HILLSBORO, Ore. -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Thermo Scientific Nicolet RaptIR FTIR Microscope. It enables users of varying experience levels to quickly locate areas of interest, collect high-spatial resolution visual and infrared data, and [...]
ERS Genomics team expands with new hire, Ralph Vogelsang
February 3, 2022
Dr. Ralph Vogelsang joins as Senior Director for Business Development & Licensing, EMEA Dublin, Ireland -- ERS Genomics Limited (‘ERS’) is pleased to welcome latest hire, Dr. Ralph Vogelsang. Ralph brings over three decades of biotechnology experience to his new role. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to [...]
NEMIS Technologies Ltd. closes CHF 7.75 million Series A Funding Round
February 3, 2022
NEMIS Technologies Ltd. closes CHF 7.75 million Series A Funding Round Investment will enable the Swiss Biotech Startup to further scale up its production, boost product development and pursue its ambitious internationalization strategy to meet increasing global demand Dübendorf, Zurich - NEMIS Technologies Ltd., amongst the Top 15 Swiss Biotech Startups of 2021, announces the [...]

